Pituitary growth hormone (GH) is a major modulator of IGF1 levels, and individuals with congenital GH deficiency (e.g. Laron syndrome) or hypopituitarism are growth-retarded in the third trimester with reduced IGF1 at birth (Randhawa & Cohen 2005). The gene discussed is GH1; the disease is Laron syndrome.